Literature DB >> 10557281

Mechanism by which the IFN-beta enhanceosome activates transcription.

J Yie1, K Senger, D Thanos.   

Abstract

We demonstrate that in contrast to previous findings by using simple synthetic promoters or activators, the natural IFN-beta enhanceosome activates transcription by causing a dramatic increase of the rate by which preinitiation complexes assemble at the promoter. This effect totally depends on the recruitment of the CBP-PolII holoenzyme by the enhanceosome, because its depletion from the extract decelerates the rate of transcription. However, addition of the CBP-PolII holoenzyme back to these extracts fully restores the speed by which the enhanceosome activates transcription. Strikingly, preincubation of the enhanceosome with the CBP-RNA PolII holoenzyme complex results in instant assembly of preinitiation complexes. In contrast, individual IFN-beta gene activators function solely by increasing the number of functional preinitiation complexes and not the rate of their assembly. Thus, fast recruitment of the CBP-RNA PolII holoenzyme complex is critical for the rapid activation of IFN-beta gene expression by virus infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557281      PMCID: PMC23908          DOI: 10.1073/pnas.96.23.13108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Enhancement of TBP binding by activators and general transcription factors.

Authors:  X Y Li; A Virbasius; X Zhu; M R Green
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

2.  Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme.

Authors:  L Kuras; K Struhl
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

3.  Differential regulation of transcription preinitiation complex assembly by activator and repressor homeo domain proteins.

Authors:  F B Johnson; M A Krasnow
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

4.  Functional steps in transcription initiation and reinitiation from the major late promoter in a HeLa nuclear extract.

Authors:  D K Hawley; R G Roeder
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

5.  Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.

Authors:  M Merika; A J Williams; G Chen; T Collins; D Thanos
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

6.  The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome.

Authors:  J Yie; M Merika; N Munshi; G Chen; D Thanos
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

7.  Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

8.  Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator.

Authors:  B L Kee; J Arias; M R Montminy
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

9.  The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.

Authors:  T K Kim; T Maniatis
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

10.  The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes.

Authors:  J White; C Brou; J Wu; Y Lutz; V Moncollin; P Chambon
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  37 in total

1.  Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia.

Authors:  M E Bianchi; M Beltrame
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

Review 2.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

3.  Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein.

Authors:  A J Shaywitz; S L Dove; J M Kornhauser; A Hochschild; M E Greenberg
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.

Authors:  Kristina M Johnson; Jin Wang; Andrea Smallwood; Charina Arayata; Michael Carey
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

5.  Bypassing the requirements for epigenetic modifications in gene transcription by increasing enhancer strength.

Authors:  George Koutroubas; Menie Merika; Dimitris Thanos
Journal:  Mol Cell Biol       Date:  2007-11-19       Impact factor: 4.272

6.  Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.

Authors:  Gyanendra Singh; Siddhesh Aras; Arnold H Zea; Shahriar Koochekpour; Ashok Aiyar
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

7.  An atomic model of the interferon-beta enhanceosome.

Authors:  Daniel Panne; Tom Maniatis; Stephen C Harrison
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

8.  3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.

Authors:  Yijun Du; Jingshan Bi; Jiyu Liu; Xing Liu; Xiangju Wu; Ping Jiang; Dongwan Yoo; Yongguang Zhang; Jiaqiang Wu; Renzhong Wan; Xiaomin Zhao; Lihui Guo; Wenbo Sun; Xiaoyan Cong; Lei Chen; Jinbao Wang
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Robust simplifications of multiscale biochemical networks.

Authors:  Ovidiu Radulescu; Alexander N Gorban; Andrei Zinovyev; Alain Lilienbaum
Journal:  BMC Syst Biol       Date:  2008-10-14

10.  The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection.

Authors:  Jim B Boonyaratanakornkit; Emmalene J Bartlett; Emerito Amaro-Carambot; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.